Fierce Biotech: EQRx’s affordable drug drive leads to Absci discovery pact

Fierce Biotech’s Nick Paul Taylor covered Absci’s recent alliance with EQRx alliance and explored how the companies are working together to lower the costs of drug discovery and cell line development.